# A Phase I/II Study of the Use of Intensity Modulated Radiotherapy (IMRT) in Cancer of the Thyroid, Larynx and Hypopharynx

> **NCT02055989** · PHASE1,PHASE2 · COMPLETED · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 105 (actual)

## Conditions studied

- Locally Advanced Larynx, Hypopharyngeal Squamous Cell Cancers
- Locally Advanced Thyroid Cancers

## Interventions

- **RADIATION:** Dose-escalated radiotherapy level 1
- **RADIATION:** Sequential dose-escalated radiotherapy level 2

## Key facts

- **NCT ID:** NCT02055989
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** 2011-12
- **Final completion:** —
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2014-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02055989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02055989, "A Phase I/II Study of the Use of Intensity Modulated Radiotherapy (IMRT) in Cancer of the Thyroid, Larynx and Hypopharynx". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02055989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*